Publicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (23)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

2022

  1. Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4)

    Nature Medicine

  2. Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

    Nature Medicine, Vol. 28, Núm. 3, pp. 557-567

2021

  1. Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

  2. Inner ear drug delivery through a cochlear implant: Pharmacokinetics in a Macaque experimental model

    Hearing Research, Vol. 404

2020

  1. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Nature Medicine, Vol. 26, Núm. 6, pp. 878-885

  2. First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma

    Clinical Cancer Research, Vol. 26, Núm. 10, pp. 2308-2317

2017

  1. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy

    Open Heart, Vol. 4, Núm. 2

2016

  1. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

    Nature Communications, Vol. 7

  2. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  2. Bone metastases in lung cancer: Potential novel approaches to therapy

    American Journal of Respiratory and Critical Care Medicine, Vol. 192, Núm. 7, pp. 799-809

  3. Characterization of large structural genetic mosaicism in human autosomes

    American Journal of Human Genetics, Vol. 96, Núm. 3, pp. 487-497

  4. Consensus nomenclature for CD8+ T cell phenotypes in cancer

    OncoImmunology, Vol. 4, Núm. 4

2014

  1. CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma

    Oncotarget, Vol. 5, Núm. 16, pp. 6854-6866

  2. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2012

  1. ERK1/2 regulation of CD44 modulates oral cancer aggressiveness

    Cancer Research, Vol. 72, Núm. 1, pp. 365-374

2001

  1. Proliferation, differentiation and apoptosis in connexin43-null osteoblasts

    Cell Communication and Adhesion, Vol. 8, Núm. 4-6, pp. 367-371

2000

  1. Differential regulation of cadherins by dexamethasone in human osteoblastic cells

    Journal of Cellular Biochemistry, Vol. 77, Núm. 3, pp. 499-506

  2. Proliferation, differentiation and apoptosis in connexin43-null osteoblasts

    Cell Adhesion and Communication, Vol. 8, Núm. 4-6, pp. 367-371